Mizutani, T <br/><br/>
Effect of steroid add-back therapy on the proliferative activity of uterine leiomyoma cells under gonadotropin-releasing hormone agonist therapy.  [electronic resource] 

 -  Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology  Feb 2005 
 - 80-3 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0951-3590 
<br/><br/><label>Standard No.: </label>10.1080/09513590400021029  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antineoplastic Agents, Hormonal--administration & dosage<br/>Cell Proliferation--drug effects<br/>Drug Administration Schedule<br/>Estrogens, Conjugated (USP)--administration & dosage<br/>Female<br/>Gonadotropin-Releasing Hormone--agonists<br/>Humans<br/>Hysterectomy<br/>Leiomyoma--pathology<br/>Leuprolide--administration & dosage<br/>Medroxyprogesterone Acetate--administration & dosage<br/>Middle Aged<br/>Neoplasm Recurrence, Local--pathology<br/>Postoperative Period<br/>Treatment Outcome<br/>Uterine Neoplasms--pathology